A Feasibility and Safety Study of CD38 CAR-T Cell Immunotherapy for Relapsed B-cell Acute Lymphoblastic Leukemia After CD19 CAR-T Adoptive Cellular Immunotherapy

Name: A Feasibility and Safety Study of CD38 CAR-T Cell Immunotherapy for Relapsed B-cell Acute Lymphoblastic Leukemia After CD19 CAR-T Adoptive Cellular Immunotherapy
License: Public Domain

Chinese PLA General Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

relapsed b-cell acute lymphoblastic leukemia after cd19 car-t aci

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 181780
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.